US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 8.550
  • +0.010+0.12%
Close Nov 29 13:00 ET
  • 8.550
  • 0.0000.00%
Post 17:01 ET
312.36MMarket Cap-2722P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
35M
0
-95.29%12.6M
0
0
0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
Operating revenue
--0
--35M
--0
-95.29%12.6M
--0
--0
--0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
Cost of revenue
Gross profit
Operating expense
13.65%48M
15.24%47.75M
24.79%45.48M
14.08%157.48M
5.98%37.24M
24.23%42.23M
9.21%41.44M
17.70%36.45M
53.91%138.04M
35.02%35.14M
Selling and administrative expenses
-4.19%12.11M
-7.28%12.46M
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
-General and administrative expense
-4.19%12.11M
-7.28%12.46M
6.51%12.7M
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
Research and development costs
19.74%36.69M
25.78%36.71M
34.89%34.53M
16.37%113.3M
9.27%27.78M
28.02%30.64M
8.46%29.19M
21.34%25.6M
63.99%97.36M
46.22%25.42M
Other operating expenses
23.38%-803K
-19.41%-1.42M
-62.43%-1.75M
-90.44%-6.21M
-110.21%-2.9M
-50.14%-1.05M
-169.93%-1.19M
-44.70%-1.08M
67.95%-3.26M
-44.31%-1.38M
Operating profit
-13.65%-48M
69.23%-12.75M
-90.68%-45.48M
-211.81%-144.89M
-298.48%-37.24M
-191.11%-42.23M
-1,197.93%-41.44M
-119.62%-23.85M
-49.20%129.59M
-91.25%18.76M
Net non-operating interest income expense
-0.36%8.01M
-2.80%7.82M
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
6.97M
Non-operating interest income
-0.36%8.01M
-2.80%7.82M
-5.92%7.39M
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
--6.97M
Other net income (expense)
-505.97%-3.13M
-79.45%67K
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
Other non- operating income (expenses)
-505.97%-3.13M
-79.45%67K
26.93%2.09M
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
Income before tax
-29.00%-43.12M
85.28%-4.87M
-150.85%-36M
-173.30%-109.03M
-223.93%-28.19M
-1,582.88%-33.42M
-491.66%-33.07M
-112.01%-14.35M
-42.01%148.74M
-89.85%22.75M
Income tax
289.92%2.24M
83.52%2.26M
84.65%2.21M
-93.07%3.61M
3.05%2.36M
60.33%-1.18M
-56.27%1.23M
-97.60%1.2M
24.18%52.08M
-94.15%2.29M
Net income
-40.68%-45.36M
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
Net income continuous Operations
-40.68%-45.36M
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
Minority interest income
Net income attributable to the parent company
-40.68%-45.36M
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.68%-45.36M
79.22%-7.13M
-145.75%-38.22M
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
Basic earnings per share
-16.67%-1.05
81.25%-0.18
-143.18%-1.07
-215.81%-3.15
-246.55%-0.85
-3,100.00%-0.9
-700.00%-0.96
-122.45%-0.44
-55.41%2.72
-88.97%0.58
Diluted earnings per share
-16.67%-1.05
81.25%-0.18
-143.18%-1.07
-223.05%-3.15
-254.55%-0.85
-3,100.00%-0.9
-740.00%-0.96
-124.18%-0.44
-54.93%2.56
-88.75%0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 035M0-95.29%12.6M000-91.74%12.6M-22.38%267.63M-77.59%53.91M
Operating revenue --0--35M--0-95.29%12.6M--0--0--0-91.74%12.6M-22.38%267.63M-77.59%53.91M
Cost of revenue
Gross profit
Operating expense 13.65%48M15.24%47.75M24.79%45.48M14.08%157.48M5.98%37.24M24.23%42.23M9.21%41.44M17.70%36.45M53.91%138.04M35.02%35.14M
Selling and administrative expenses -4.19%12.11M-7.28%12.46M6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M
-General and administrative expense -4.19%12.11M-7.28%12.46M6.51%12.7M14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M
Research and development costs 19.74%36.69M25.78%36.71M34.89%34.53M16.37%113.3M9.27%27.78M28.02%30.64M8.46%29.19M21.34%25.6M63.99%97.36M46.22%25.42M
Other operating expenses 23.38%-803K-19.41%-1.42M-62.43%-1.75M-90.44%-6.21M-110.21%-2.9M-50.14%-1.05M-169.93%-1.19M-44.70%-1.08M67.95%-3.26M-44.31%-1.38M
Operating profit -13.65%-48M69.23%-12.75M-90.68%-45.48M-211.81%-144.89M-298.48%-37.24M-191.11%-42.23M-1,197.93%-41.44M-119.62%-23.85M-49.20%129.59M-91.25%18.76M
Net non-operating interest income expense -0.36%8.01M-2.80%7.82M-5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M6.97M
Non-operating interest income -0.36%8.01M-2.80%7.82M-5.92%7.39M179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M--6.97M
Other net income (expense) -505.97%-3.13M-79.45%67K26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M
Other non- operating income (expenses) -505.97%-3.13M-79.45%67K26.93%2.09M-47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M
Income before tax -29.00%-43.12M85.28%-4.87M-150.85%-36M-173.30%-109.03M-223.93%-28.19M-1,582.88%-33.42M-491.66%-33.07M-112.01%-14.35M-42.01%148.74M-89.85%22.75M
Income tax 289.92%2.24M83.52%2.26M84.65%2.21M-93.07%3.61M3.05%2.36M60.33%-1.18M-56.27%1.23M-97.60%1.2M24.18%52.08M-94.15%2.29M
Net income -40.68%-45.36M79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M
Net income continuous Operations -40.68%-45.36M79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M
Minority interest income
Net income attributable to the parent company -40.68%-45.36M79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.68%-45.36M79.22%-7.13M-145.75%-38.22M-216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M
Basic earnings per share -16.67%-1.0581.25%-0.18-143.18%-1.07-215.81%-3.15-246.55%-0.85-3,100.00%-0.9-700.00%-0.96-122.45%-0.44-55.41%2.72-88.97%0.58
Diluted earnings per share -16.67%-1.0581.25%-0.18-143.18%-1.07-223.05%-3.15-254.55%-0.85-3,100.00%-0.9-740.00%-0.96-124.18%-0.44-54.93%2.56-88.75%0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data